Targeted DNA/RNA Sequencing Market Emerging Growth Analysis, Future Demand and Business Opportunities 2031

The field of genetic research and diagnostics has witnessed significant strides with the advent of targeted DNA/RNA sequencing methods. Targeted sequencing, particularly RNA-Seq, has emerged as a rapid and cost-effective approach for detecting known and novel variants in selected genes or genomic regions. This article delves into the key drivers, market segmentation, and major players shaping the global landscape of targeted DNA/RNA sequencing.

Market Drivers:

Continuous technological advancements and the increased availability of innovative and cost-effective sequencing platforms are driving the global targeted DNA/RNA sequencing market. The utilization of next-generation sequencing methods, such as exome sequencing and RNA-Seq, in research and development is projected to fuel market growth. Major players are contributing to this growth by launching new products. For instance, Roche Molecular Systems, Inc. introduced the Exome and Custom KAPA Target Enrichment portfolio, showcasing the industry's commitment to advancing sequencing capabilities.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=83683&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

Market Segmentation:

Type Segmentation:

DNA-based Targeted Sequencing: This method is anticipated to lead the market during the forecast period due to its cost-effectiveness, time efficiency, and the availability of diverse products facilitating DNA sequencing.

RNA-based Targeted Sequencing: Providing both quantitative and qualitative information, this approach offers a focused analysis of specific transcripts of interest.

Application Segmentation:

Drug Discovery: The dominant segment, with exome sequencing and related methods being commonly preferred for drug discovery efforts.

Human Biomedical Research, Plant & Animal Sciences, Others: Each segment caters to specific research needs, contributing to the overall growth of the targeted DNA/RNA sequencing market.

End-User Segmentation:

Hospitals & Clinics, Academic & Research Institutes, Pharma & Biotech Companies: Academic and research institutes held a significant market share in 2020, with an anticipated strong growth trajectory. The surge is attributed to increased research and development activities and scholarships offered for NGS-based PhD projects.
Regional Analysis:

North America:

Market Dominance: North America is expected to dominate the global market, driven by the presence of numerous genome centers, installed sequencers, and major industry players.

Market Dynamics: However, there is an expected decline in market share by 2027. The effective regulatory bodies and continuous technological advancements are significant factors contributing to the region's market growth.

Asia Pacific:

High CAGR: The targeted DNA/RNA sequencing market in Asia Pacific is poised to expand at a high compound annual growth rate (CAGR) during the forecast period. This growth can be attributed to increasing research activities and adoption of sequencing technologies in the region.
Key Players:

Key players in the global targeted DNA/RNA sequencing market include Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Thermo Fisher Scientific, Inc., QIAGEN, Perkin Elmer, Inc., Bio-Rad Laboratories, Inc., GATC Biotech AG, DNASTAR, Inc., Integrated DNA Technologies, Inc., RainDance Technologies, Inc., and other prominent industry contributors.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=83683<ype=S&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

The global targeted DNA/RNA sequencing market is propelled by technological advancements, the introduction of new products, and increasing research and development activities. As the industry continues to evolve, collaboration between academia, research institutes, and industry players is expected to further drive innovation in the field of genetic sequencing, contributing to advancements in healthcare, drug discovery, and beyond.

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.